Biologic & Advanced Immunomodulatory Therapy

We emphasize the judicious use of biologic and advanced immunomodulatory therapies in the management of pediatric rheumatic and immune-mediated diseases. This includes careful initiation and ongoing monitoring of conventional DMARDs and biologic agents such as methotrexate, TNF inhibitors, IL-1 and IL-6 inhibitors, and JAK inhibitors.

Our approach prioritizes rigorous safety surveillance for infections, laboratory abnormalities, vaccine guidance and thorough education of families to ensure the safe and effective long-term use of immunosuppressive therapies.